Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome

  • Mark Duane GoodmanEmail author
Reference work entry


In the arc of a generation, physicians, chemists and pharmacists, nurses, public health specialists, community activists, patients, and their loved ones have transmuted an illness of immense suffering and certain death into a largely manageable illness, dependent on resources and health information.


Human Immunodeficiency Virus Viral Load Human Immunodeficiency Virus Infection Herpes Zoster Human Immunodeficiency Virus Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Duesberg PH. AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc Natl Acad Sci. 1991;88(4):1575–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 1999. 2010;53(5):619–24.Google Scholar
  3. 3.
    Hall HI, Song R, Szwarcwald CL, Green T. Brief report: time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr. 2015;69(2):248–51.CrossRefPubMedGoogle Scholar
  4. 4.
    Fox J, White PJ, Macdonald N, Weber J, McClure M, Fidler S, et al. Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men. HIV Med. 2009;10(7):432–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Piot P, Quinn TC. Response to the AIDS pandemic – a global health model. N Engl J Med. 2013;368(23):2210–8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Young M, Wolfheim C, Marsh DR, Hammamy D. World Health Organization/United Nations Children’s Fund Joint Statement on integrated community case management: an equity-focused strategy to improve access to essential treatment services for children. Am J Trop Med Hyg. 2012;87 Suppl 5:6–10.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Moyer VA. Screening for HIV: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159(1):51–60.CrossRefPubMedGoogle Scholar
  8. 8.
    Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Center Dis Control. 2015;64(RR-03):1–137.Google Scholar
  9. 9.
    Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505–10.CrossRefPubMedGoogle Scholar
  10. 10.
    Rosales-Statkus ME, de la Fuente L, Fernández-Balbuena S, Figueroa C, Fernàndez-López L, Hoyos J, et al. Approval and potential use of over-the-counter HIV self-tests: the opinion of participants in a street based HIV rapid testing program in Spain. AIDS Behav. 2015;19(3):472–84.CrossRefPubMedGoogle Scholar
  11. 11.
    Spielberg F, Branson BM, Goldbaum GM, Lockhart D, Kurth A, Celum CL, et al. Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. J Acquir Immune Defic Syndr 1999. 2003;32(3):318–27.CrossRefGoogle Scholar
  12. 12.
    Branson BM, Owen SM, Wesolowski LG, Bennett B, Werner BG, Wroblewski KE, et al. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Cent Dis Control Prev Assoc Public Health Lab [Internet]. 2014 [cited 2015 Sep 13]; Available from:
  13. 13.
    Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;civ778.Google Scholar
  14. 14.
    Centers for Disease Control. Preexposure prophylaxis for HIV prevention in the United States-2013: a clinical practice guideline. [Internet]. [cited 2015 Sep 18]. Available from:
  15. 15.
    Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. [Internet]. [cited 2015 Sep 20]. Available from:
  16. 16.
    Ford N, Mayer KH, Barlow L, Bagyinszky F, Calmy A, Chakroun M, et al. World Health Organization Guidelines on postexposure prophylaxis for HIV: recommendations for a public health approach. Clin Infect Dis. 2015;60 Suppl 3:S161–4.CrossRefPubMedGoogle Scholar
  17. 17.
    HIV/AIDS Treatment Guidelines [Internet]. AIDSinfo. [cited 2015 Sep 7]. Available from:
  18. 18.
    Tyerman Z, Aboulafia DM. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy. AIDS Rev. 2012;14(1):3–16.PubMedGoogle Scholar
  19. 19.
    Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS. 2003;17:S141–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Gupta AK, Daigle D, Foley KA. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. J Eur Acad Dermatol Venereol. 2015;29(6):1039–44.CrossRefPubMedGoogle Scholar
  21. 21.
    Lai TY, Wong RL, Luk FO, Chow VW, Chan CK, Lam DS. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Experiment Ophthalmol. 2011;39(2):99–104.CrossRefPubMedGoogle Scholar
  22. 22.
    Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183(3):388–95.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13(8):453–68.PubMedGoogle Scholar
  24. 24.
    Bogoch I, Andrews J, Nagami E, Rivera A, Gandhi R, Stone D. Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults. HIV Med. 2013;14(3):182–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Arenas-Pinto A, Grant A, Bhaskaran K, Copas A, Carr A, Worm SW, et al. Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis. Antivir Ther. 2011;16(2):219.CrossRefPubMedGoogle Scholar
  26. 26.
    Raza S, Chaudhry NA, Brown JD, Aghaie S, Rezai D, Khan A, et al. To study the clinical, biochemical and radiological features of acute pancreatitis in HIV and AIDS. J Clin Med Res. 2013;5(1):12–7.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Kumar MSA, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int. 2005;67(4):1622–9.CrossRefPubMedGoogle Scholar
  28. 28.
    McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010;51(8):937–46.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin Infect Dis. 2001;32(8):1221–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Meeker RB, Asahchop E, Power C. The brain and HAART: collaborative and combative connections. Curr Opin HIV AIDS. 2014;9(6):579–84.CrossRefPubMedGoogle Scholar
  31. 31.
    Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;civ578.Google Scholar
  32. 32.
    Doherty T, Chopra M, Jackson D, Goga A, Colvin M, Persson L-A. Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS. 2007;21(13):1791–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Adato M, Kadiyala S, Roopnaraine T, Biermayr-Jenzano P, others. Studies of vulnerable children and orphans in three provinces in South Africa. 2015 [cited 2015 Sep 13]; Available from:
  34. 34.
    Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308(5728):1582–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Martin CP, Fain MJ, Klotz SA. The older HIV-positive adult: a critical review of the medical literature. Am J Med. 2008;121(12):1032–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Family MedicineCreighton UniversityOmahaUSA

Personalised recommendations